Solana Beach, CA, United States of America

Cara Ann Tracewell

This inventor holds 19 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Biochemical Engineering. Top assignee: Genomatica, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cara Ann Tracewell. Retrieved from https://idiyas.com/inventor/cara-ann-tracewell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

San Diego, CA (US) (2020 - 2023)
Solana Beach, CA (US) (2016 - 2024)

Company Filing History:

19 out of 209

Genomatica, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Microorganisms

Reducing Equivalents

1,4-Butanediol

Succinate

Diamines

3-Hydroxybutyryl-CoA

Methanol

Caprolactam

Methacrylic Acid

Aldehyde Dehydrogenase

Glycerol

Hexamethylenediamine

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12668820 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto (2026-06-30),

2. 12264354 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto (2025-04-01),

3. 12203102 - 3-hydroxybutyryl-CoA dehydrogenase variants and methods of use (2025-01-21),

4. 11898172 - 3-hydroxybutyryl-CoA dehydrogenase variants and methods of use (2024-02-13),

5. 11753663 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto (2023-09-12),

6. 11702682 - Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism (2023-07-18),

7. 11629363 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,2-propanediol, n-propanol, 1,3-propanediol, or glycerol related thereto (2023-04-18),

8. 11535874 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing succinate related thereto (2022-12-27),

9. 11447804 - Producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam in the presence of methanol using a microorganism having increased availability of reducing equivalents (2022-09-20),

10. 11299716 - Aldehyde dehydrogenase variants and methods of use (2022-04-12),

11. 10711289 - Method of producing and processing diamines from an engineered microorganism (2020-07-14),

12. 10640795 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing succinate related thereto (2020-05-05),

13. 10626422 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1.4-butanediol related thereto (2020-04-21),

14. 10150976 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto (2018-12-11),

15. 10000758 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, for producing methacrylic acid (2018-06-19),

Title: Cara Ann Tracewell: Pioneering Innovations in Biochemical Engineering

Introduction

Cara Ann Tracewell is a distinguished inventor based in Solana Beach, California, with an impressive record of 17 patents to her name. Her groundbreaking work primarily focuses on advancements in biochemical engineering, particularly relating to 3-hydroxybutyryl-CoA dehydrogenase. Cara's innovative contributions significantly enhance the methodologies involved in cell culture and product development in the field.

Latest Patents

Among her latest patents, Cara has developed variants of 3-hydroxybutyryl-CoA dehydrogenase, which are instrumental in synthesizing vital biochemical compounds. The patent describes the provision of thiolases and polypeptide variants of 3-hydroxybutyryl-CoA dehydrogenase, alongside the nucleic acids encoding these components. These innovations enable methods for more productive cell culture, ultimately leading to the production of compounds such as 3-hydroxybutyryl-CoA (3-HB-CoA), 3-hydroxybutyraldehyde (3-HBal), 3-hydroxybutyrate (3-HB), and 1,3-butanediol (1,3-BDO), among others. Furthermore, the applications of these products extend to various industries, showcasing Cara's impact on both research and practical applications in biochemistry.

Career Highlights

Cara Ann Tracewell has had a notable career with her association with Genomatica, Inc., where she continues to innovate within the field of biochemical engineering. Her expertise and commitment to advancing technology contribute to the company's reputation as a leader in sustainable and efficient biochemical processes.

Collaborations

Collaboration plays a significant role in Cara's research endeavors. She has worked closely with fellow professionals such as Anthony P. Burgard and Robin E. Osterhout, whose combined efforts have further pushed the boundaries of innovation in their respective fields. Together, they contribute to a collaborative environment that fosters creativity and progress in scientific research.

Conclusion

With a robust portfolio of patents and a dedicated career in biochemical innovation, Cara Ann Tracewell stands out as a leading inventor. Her contributions not only represent significant advancements in her field but also pave the way for future innovations that could revolutionize the production of essential biochemical compounds. As she continues her work at Genomatica, her impact on the industry will undeniably be felt for years to come.

Profile summary based on public USPTO records.